SkinBioTherapeutics day 1

A nervous day watching the share price of SBTX:SkinBioTherapeutics today.

My biggest fear was a tank back to the IPO price of 9p following my purchase at 8:01am.

I bought 7,486 shares at 13.9p costing £1,052.50 and with the bid price at 10p was immediately losing £300 on paper.

Fortunately the price settled for much of the day at 13.5p bid and 14p offer, so I was feeling fairly smug that I had got in cheap.

Unfortunately it dropped right at the end of the day to 13p bid and 13.5p offer, so if I'd waited a bit longer I would have been able to buy more.

I don't care really, in fact I'm made up that I would have been one of the first people to buy shares in this company on the open market. It was literally seconds after 8am.

There were 9.8 million shares traded today, which is quite spectacular. It will be very interesting to see how many are traded tomorrow, as people will be filling their ISAs at the start of the new tax year.

I'm planning on bedding some of my share account holdings into my ISA, with the main candidates 6,882 AMYT:Amryt Pharma and 81,087 JLP:Jubilee Platinum. I have high hopes that both these shares will perform well over the next few years, so sheltering them from tax will be a good thing.

It will have an odd effect on my stats. AMYT:Amryt Pharma is £102.23 in profit and JLP:Jubilee Platinum is £377.67 in profit, so it will boost my monthly performance figure, but will lose me £480 from my paper profits.

Fortunately it's been another good day overall, with KIBO:Kibo Mining climbing 9.5% and reducing my paper losses to about £450, which is about £1,000 better off than last week. Amazingly IQE:IQE went up even more, and is now £3,270 in profit. Another big gainer today was REDS:RedstoneConnect, climbing 12.1% after news of a new contract. I've only got this in my trading account, but am becoming increasingly interested as a potential long-term holding.

So the combined portfolio is up by £924 for the week and £2,427 in the black, with the combined ISA and share accounts only £769 in the red and perilously close to break-even. The overall portfolio value has gone over £63,000 so I'm allowed a "Woohoo!".

All eyes on the start of the tax year tomorrow, and will SBTX:SkinBioTherapeutics maintain its value?